Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.

Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.

<h4>Background</h4>South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,734 patients diagnosed in 2014. The number of diagnosed patients has increased substantially with the introduction of the Xpert MTB/RIF test, used for tuberculosis (TB) diagnosis for...

Full description

Bibliographic Details
Main Authors: Helen Cox, Lindy Dickson-Hall, Norbert Ndjeka, Anja Van't Hoog, Alison Grant, Frank Cobelens, Wendy Stevens, Mark Nicol
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-02-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1002238

Internet

https://doi.org/10.1371/journal.pmed.1002238

Similar Items